Skip to main navigation Skip to search Skip to main content

Protein arginine methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K pathways: A case for PRMT5 inhibition and combination therapies in cancer

  • Tzuriel Sapir
  • , David Shifteh
  • , Moshe Pahmer
  • , Sanjay Goel
  • , Radhashree Maitra

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Protein arginine methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K pathways: A case for PRMT5 inhibition and combination therapies in cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology